Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal

BACKGROUND: HBV reactivation is associated with high mortality rates in hematopoietic stem cell transplantation (HSCT) and prophylactic lamivudine (LMV) treatment is suggested to prevent this phenomenon. However, the duration of LMV treatment in HSCT patients is not fully defined and the time of imm...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Infect Dis
Autores principales: Cerva, C., Maffongelli, G., Svicher, V., Salpini, R., Colagrossi, L., Battisti, A., Mariotti, B., Cerretti, R., Cudillo, L., Sarmati, L.
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5557326/
https://ncbi.nlm.nih.gov/pubmed/28806922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-017-2672-6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares